Fundraising Fox

Glenn Batchelder

Investor

Venture Partner at Pivotal Life Sciences

Cambridge, Massachusetts

Writes $100K – $5M checks Β· typically $1.5M

About

Glenn Batchelder is a biotech executive with over 30 years of leadership experience across operations, sales, marketing, business development, manufacturing, supply chain, and R&D. He co-founded and served as CEO of Civitas Therapeutics (acquired by Acorda Therapeutics), and previously led BIND Therapeutics (acquired by Pfizer) and Acceleron Pharma (acquired by Merck), after beginning his career at Millennium Pharmaceutical. He holds a BS in Chemical Engineering from Lehigh University.

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Pivotal bioVenture PartnersVenture Partnercurrent2022 β€” present
  2. Synchronicity PharmaChairmancurrent2017 β€” present
  3. XyloCor TherapeuticsChairmancurrent2016 β€” present
  4. The Michael J. Fox Foundation for Parkinson's ResearchMember Board of Directorscurrent2015 β€” present
  5. Kantum BioChairman2018 β€” 2022
  6. The Possible ProjectMember Board of Directors2015 β€” 2021Cambridge, MA
  7. SynspiraMember Board Of Directors2017 β€” 2019
  8. MassBioMember Board of Directors2003 β€” 2018
  9. MassBioChairman of the Board of Directors2014 β€” 2016
  10. Civitas Therapeutics (acquired by Acorda Therapeutics 10/2014)Board Member2014
  11. Civitas Therapeutics (acquired by Acorda Therapeutics 10/2014)President, CEO, Founder and Board Member2009 β€” 2014
  12. BIND Therapeutics (Acquired by Pfizer 6/2016)President and CEO2007 β€” 2009
  13. Acceleron Pharma (Acquired by Merck 11/2021)President & CEO2004 β€” 2006
  14. Millennium Pharmaceuticals (Acquired by Takeda 5/2008)SVP Operations2003 β€” 2004
  15. Millennium PharmaceuticalsVP Operations1999 β€” 2003

Education

  1. Lehigh UniversityBachelor's Degree, Chemical Engineering1979 β€” 1983

Skills & more

Biotechnology28Technology Transfer16Biopharmaceuticals21FDA3Lifesciences7Pharmaceutical Industry24Drug Development12Clinical Development7Commercialization16Project Delivery1GMP3Oncology7
+5 moreRegulatory AffairsClinical TrialsLife SciencesMedical DevicesDrug Discovery

From Glenn's professional profile.

Same school

Shared employers

Investments

Board seats

OncXernaSynchronicity PharmaXyloCor Therapeutics

Per the firm's website.

Colleagues at Pivotal Life Sciences